THE PASSAGE OF RABBIT VIRULENT TYPE III PNEUMOCOCCI FROM THE RESPIRATORY TRACT OF RABBITS INTO THE LYMPHATICS AND

R Z Schulz1, M F Warren, C K Drinker

  • 1Department of Pathology, The Harvard Medical School, and the Department of Physiology, The Harvard School of Public Health, Boston.

Insights

Rabbit virulent Type III pneumococci rapidly enter lymphatics after nasal or tracheal instillation. Early antiserum administration reduced bacterial recovery in lymph and blood, suggesting a therapeutic window.

Area of Science:

  • Bacteriology
  • Immunology
  • Pathogenesis

Background:

  • Streptococcus pneumoniae, particularly virulent Type III strains, can cause severe respiratory infections.
  • Understanding the initial host-pathogen interactions and lymphatic spread is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the early lymphatic dissemination of rabbit virulent Type III pneumococci following intranasal or intratracheal inoculation.
  • To evaluate the efficacy of early intravenous antiserum administration in preventing bacterial spread.

Main Methods:

  • Rabbit virulent Type III pneumococci were instilled into the nasal or tracheal passages of rabbits.
  • Lymph and blood samples were collected over a 4-hour period to detect bacterial presence.
  • Intravenous antiserum was administered 2.5 to 3 hours prior to bacterial instillation in a subset of animals.

Main Results:

  • Pneumococci were consistently recovered from draining lymphatics within 1-4 hours post-instillation, often detectable by the first hour.
  • Bacterial presence was predominantly observed first in lymphatics, with subsequent, less frequent, recovery from the blood.
  • Pre-treatment with antiserum significantly reduced the number of animals with positive lymph or blood cultures and the duration of bacterial recovery in lymph.

Conclusions:

  • Virulent Type III pneumococci rapidly disseminate via lymphatics from the initial site of respiratory tract infection.
  • Early administration of specific antiserum can effectively limit pneumococcal spread to lymphatics and bloodstream, indicating a critical window for therapeutic intervention.

Related Concept Videos

Rabies01:28

Rabies

Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Transmission of Pathogens01:24

Transmission of Pathogens

Pathogens spread from their reservoirs to susceptible hosts through three main routes: contact transmission, vehicle transmission, and vector transmission. Each route involves distinct mechanisms of transfer.Contact TransmissionThis category includes direct contact, indirect contact, and droplet transmission:Direct contact involves immediate physical interaction between individuals—such as a handshake—which can spread pathogens like Streptococcus pyogenes, the bacterium responsible for...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...